Log in

Relevant bibliographies by topics / Neovascularisation / Journal articles

To see the other types of publications on this topic, follow the link: Neovascularisation.

Journal articles on the topic 'Neovascularisation'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Neovascularisation.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Nazm, Nazneen, Nadeem, and Madhura Mukherjee. "To study the extent of regression of retinal neovascularisation in proliferative diabetic retinopathy following laser photocoagulation of the ischaemic retina." Indian Journal of Clinical and Experimental Ophthalmology 11, no. 1 (2025): 24–30. https://doi.org/10.18231/j.ijceo.2025.005.

Full text

Abstract:

Eyes with proliferative diabetic retinopathy have a variable response to treatment with panretinal photocoagulation (PRP) or anti–vascular endothelial growth factor agents. We undertook this study to find out what is the exact extent of regression of neovascularisation with PRP and what are the factors that correlate with this variation in response. Present Prospective Study was conducted in Subjects with Proliferative Diabetic Retinopathy attending the ophthalmology department at ESI-PGIMSR and Model Hospital, Basaidarapur, New Delhi from October 2019-April 2021. During the above-mentioned pe

APA, Harvard, Vancouver, ISO, and other styles

2

Creton, D. "Neovascularisation." Phlebologie 37, no. 03 (2008): 134–41. http://dx.doi.org/10.1055/s-0037-1622223.

Full text

Abstract:

SummaryThere are different causes of neovascularisation: vascular endothelial growth factor, inflammatory process, hypertrophy of pre-existant vessels (lymph node veins), haematomas revascularisation, and high difference in pressure. The latter 3 depend directly on the way the operation is performed hence on the surgeon.Concerning the primary varices patch saphenoplasty do not abolish neovascularisation. It is of first importance to perform a flush ligation only in case of incontinent terminal and pre-terminal valves. In that case an incision as small as possible must be carried out with minim

APA, Harvard, Vancouver, ISO, and other styles

3

Holmgren, L. "Malignant Neovascularisation." European Journal of Ultrasound 6 (November 1997): S11. http://dx.doi.org/10.1016/s0929-8266(97)87215-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Smith, R. "Neovascularisation again." British Journal of Ophthalmology 74, no. 6 (1990): 323. http://dx.doi.org/10.1136/bjo.74.6.323.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Badal, Josep, Luis Amselem, Ricardo Aleman, and Frederic Huste. "Anti–vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularisation." European Ophthalmic Review 07, no. 02 (2013): 84. http://dx.doi.org/10.17925/eor.2013.07.02.84.

Full text

Abstract:

Pathological myopia represents the most common cause of choroidal neovascularisation in young patients. Its natural course has a devastating prognosis. Several treatments have been assessed, but photodynamic therapy is currently the only approved treatment for subfoveal choroidal neovascularisation related to pathological myopia. Anti-vascular endothelial growth factor therapy has demonstrated promising results in any form and localisation of choroidal neovascularisation, although there is an absence of data obtained from randomised clinical trials. The aim of this article is to compare differ

APA, Harvard, Vancouver, ISO, and other styles

6

Shehadeh, Mohammad M., Mohammad T. Akkawi, Vasilios F. Diakonis, Ammar A. Aghbar, and Abdelraheem Abu Shanab. "Extensive Corneal Neovascularisation Treatment by Ultraviolet Corneal Collagen Crosslinking." European Ophthalmic Review 11, no. 01 (2017): 62. http://dx.doi.org/10.17925/eor.2017.11.01.62.

Full text

Abstract:

The purpose of this article is to report a case of extensive corneal neovascularisation that was treated by ultraviolet corneal collagen crosslinking (CXL). The case report is about a 24-year-old man who was referred to the cornea clinic with a case of keratitis. He was treated with topical antibiotics. After full resolution of keratitis, his condition was complicated by extensive corneal neovascularisation. A trial of photochemical corneal collagen CXL with riboflavin/ultraviolet A resulted in a dramatic improvement and resolution of the corneal neovascularisation. Thus, we can conclude that

APA, Harvard, Vancouver, ISO, and other styles

7

Chan, Elsie, Jennifer Fan Gaskin, and Elsa C. Chan. "Corneal Neovascularisation and Anti-VEGF Therapy." Targets 3, no. 1 (2025): 9. https://doi.org/10.3390/targets3010009.

Full text

Abstract:

Cornea vascularisation is a significant cause of ocular morbidity. Disease or injury often triggers the development of new blood vessels in the cornea, compromising its clarity and impairing vision. Common causes of corneal neovascularisation include infections, chemical burns, and local and systemic inflammatory disorders. Topical corticosteroid eye drops remain the standard therapy; however, extended use of corticosteroids has been known to cause side-effects including cataracts and raised intraocular pressure. As such, an alternative therapy has been actively sought. Vascular endothelial gr

APA, Harvard, Vancouver, ISO, and other styles

8

Imre, G. "Lactic acid neovascularisation." British Journal of Ophthalmology 75, no. 4 (1991): 254. http://dx.doi.org/10.1136/bjo.75.4.254.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Cheng, Jacob YC, Doric WK Wong, and Chong Lye Ang. "Intraocular Avastin (Bevacizumab) for Neovascularisation of the Iris and Neovascular Glaucoma." Annals of the Academy of Medicine, Singapore 37, no. 1 (2008): 72–74. http://dx.doi.org/10.47102/annals-acadmedsg.v37n1p72.

Full text

Abstract:

Introduction: The aim of this study was to determine the effectiveness of intraocular injections of bevacizumab for neovascularisation of the iris and neovascular glaucoma. Clinical Picture: Three patients with neovascularisation of the iris due to various causes were recruited. Treatment: Patients were treated with intraocular bevacizumab. Outcome: Neovascularisation of the iris was noted to have completely regressed as early as 3 days after the injection and in all the patients (100%) within 8 days after injection. They were followed up for at least 1 month with no clinical evidence of recur

APA, Harvard, Vancouver, ISO, and other styles

10

Buragohain, Suklengmung, Harsha Bhattacharjee, and Henal Javeri. "Capsular neovascularisation in uveitis." Indian Journal of Ophthalmology - Case Reports 1, no. 3 (2021): 458. http://dx.doi.org/10.4103/ijo.ijo_3625_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Faraj, L. A., D. G. Said, and H. S. Dua. "Evaluation of corneal neovascularisation." British Journal of Ophthalmology 95, no. 10 (2011): 1343–44. http://dx.doi.org/10.1136/bjophthalmol-2011-300856.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Stavrou, D. "Neovascularisation in wound healing." Journal of Wound Care 17, no. 7 (2008): 298–302. http://dx.doi.org/10.12968/jowc.2008.17.7.30521.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Sunness, J. S. "Choroidal neovascularisation and atrophy." British Journal of Ophthalmology 90, no. 4 (2006): 398–99. http://dx.doi.org/10.1136/bjo.2005.084830.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Sivaprasad, S., and A. T. Moore. "Choroidal neovascularisation in children." British Journal of Ophthalmology 92, no. 4 (2008): 451–54. http://dx.doi.org/10.1136/bjo.2007.124586.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Binns, Malcolm, and Robert W. H. Pho. "Neovascularisation of the epiphysis." Microsurgery 12, no. 1 (1991): 9–13. http://dx.doi.org/10.1002/micr.1920120103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Carrozzo, Alessandro, Jobe Shatrov, Abdo El Helou, et al. "Ultrasound-guided electrocoagulation of neovascularisation for persistent patellar tendinopathy in athletes: a cohort study of 25 patients with a mean follow-up of 5 years from the SANTI Study Group." BMJ Open Sport & Exercise Medicine 10, no. 1 (2024): e001900. http://dx.doi.org/10.1136/bmjsem-2024-001900.

Full text

Abstract:

BackgroundPatellar tendinopathy (PT) is a common condition characterised by persistent patellar tendon pain and dysfunction, particularly in athletes. Neovascularisation is frequently observed in the PT and is associated with increased pain. Ultrasound-guided electrocoagulation of neovascularisation has emerged as a minimally invasive alternative treatment for recalcitrant PT.Hypothesis/purposeThe purpose of this study was to evaluate the clinical outcomes of ultrasound-guided electrocoagulation of neovascularisation in athletes with persistent PT.Study designCase series; level of evidence, IV

APA, Harvard, Vancouver, ISO, and other styles

17

Wali, Keerti, Shilpa Maled, Ronak Solanki, Apoorva G. Ayachit, and Aniket N. Shastri. "Safety and efficacy of frequency-doubled Nd-YAG laser photocoagulation of different types of corneal neovascularisation (NLPC): a prospective study." BMJ Open Ophthalmology 10, no. 1 (2025): e001734. https://doi.org/10.1136/bmjophth-2024-001734.

Full text

Abstract:

PurposeFrequency doubling of neodymium-doped yttrium aluminum garnet (Nd-YAG) laser results in emission of photocoagulating 532 nm light compared with photolytic 1064 nm emission. The ergonomic benefits of solid-state lasers led to replacement of older coagulating lasers in ophthalmic centres by frequency-doubled Nd-YAG laser. Our study aims to evaluate safety and efficacy of frequency-doubled Nd-YAG laser for photocoagulation of corneal neovascularisation (NLPC).Methods30 quiet eyes of 28 patients with superficial, mid-stromal and deep stromal inactive corneal neovascularisation were subjecte

APA, Harvard, Vancouver, ISO, and other styles

18

Bobryshev, Y. V., A. E. Farnsworth, and R. S. A. Lord. "Expression of Vascular Endothelial Growth Factor in Aortocoronary Saphenous Vein Bypass Grafts." Cardiovascular Surgery 9, no. 5 (2001): 492–98. http://dx.doi.org/10.1177/096721090100900515.

Full text

Abstract:

Neovascularisation is a prominent feature of long-term aortocoronary saphenous vein bypass grafts but mechanisms involved in the formation of neovessels have not been previously studied. Vascular Endothelial Growth Factor (VEGF) is an important angiogenic factor that induces migration and proliferation of endothelial cells, enhances permeability and modulates thrombogenecity. This study investigated the expression of VEGF in aortocoronary saphenous vein bypass grafts. Aortocoronary saphenous vein bypass grafts with angiographic luminal stenosis of >75% were explanted from 14 patients at red

APA, Harvard, Vancouver, ISO, and other styles

19

Bainbridge, James W., Vanya Loroch, Eric Viaud, and Claus Cursiefen. "Beyond Anti-VEGFs – Anti-Insulin Receptor Substrate-1 Oligonucleotides as a Novel Approach to Ocular Neovascular Disorders." European Ophthalmic Review 06, no. 03 (2012): 190. http://dx.doi.org/10.17925/eor.2012.06.03.190.

Full text

Abstract:

Angiogenesis is a complex process that is vital to health but is also a driving factor behind a broad range of malignant, ischaemic, inflammatory, infectious and immune disorders. For optimal efficacy and safety, therapies aimed at preventing angiogenic-mediated disorders must differentiate between healthy and pathological angiogenesis or neovascularisation. Aganirsen is an antisense oligonucleotide that inhibits the insulin receptor substrate (IRS)-1 angiogenic pathway by targeting the IRS-1 messenger RNA. To date, studies of aganirsen have focused mainly on ocular disorders because of the ab

APA, Harvard, Vancouver, ISO, and other styles

20

Diamond, Michael Adam, Sze Wah Samuel Chan, Xun Zhou, et al. "Lymphatic vessels identified in failed corneal transplants with neovascularisation." British Journal of Ophthalmology 103, no. 3 (2018): 421–27. http://dx.doi.org/10.1136/bjophthalmol-2018-312630.

Full text

Abstract:

BackgroundCorneal transplant failure with neovascularisation is a leading indication for full-thickness grafts in patients. Lymphangiogenesis is implicated in the pathology of graft failure, and here we systematically evaluate failed human corneal transplants with neovascularisation for the presence of lymphatic vessels.MethodsNine failed grafts with neovascularisation, based on H&E staining with subsequent immunoperoxidase staining for CD31, a blood vessel marker, were selected. Lymphatics were investigated by immunohistochemical and immunofluorescence approaches using podoplanin as a lym

APA, Harvard, Vancouver, ISO, and other styles

21

Oki, Aqsa Sjuhada, Moch Febi Alviansyah, Christian Khoswanto, Retno Pudji Rahayu, and Muhammad Luthfi. "Acceleration of post-tooth extraction socket healing after continuous aerobic and anaerobic physical exercise in Wistar rats (Rattus norvegicus)." Dental Journal (Majalah Kedokteran Gigi) 53, no. 4 (2020): 196. http://dx.doi.org/10.20473/j.djmkg.v53.i4.p196-200.

Full text

Abstract:

Background: Physical exercise has been proven to accelerate wound healing. Physical training itself consists of aerobic (continuous training) and anaerobic (interval training) exercise. The effectiveness of continuous physical exercise on post-tooth extraction wound healing is the focus of this study. Purpose: This study aims to investigate the differences in post-tooth extraction wound healing in Wistar rats (Rattus norvegicus) after aerobic and anaerobic exercise based on the number of fibroblasts and neovascularisation. Methods: Wistar rats were divided into three groups: the control group

APA, Harvard, Vancouver, ISO, and other styles

22

Holló, Gábor. "Diabetic neovascularisation and secondary glaucoma." Orvosi Hetilap 152, no. 29 (2011): 1167–70. http://dx.doi.org/10.1556/oh.2011.29042.

Full text

Abstract:

Neovascular glaucoma develops from intraocular neovascularisation in diabetes mellitus. Neovascularisation is a consequence of hypoxia-induced production of vascular endothelial growth factor-A. Neovascular glaucoma is one of the most serious, sight-threatening late complications of diabetes. Several intraocular pressure lowering drugs, surgical and adjunctive laser treatments have been used to treat this disease, but the efficacy of the interventions is limited. The role of vascular endothelial growth factor-A blocking therapy in the treatment of neovascular glaucoma remains to be determined.

APA, Harvard, Vancouver, ISO, and other styles

23

Augustin, Albert J., and Indre Offermann. "Combination Therapy for Choroidal Neovascularisation." Drugs & Aging 24, no. 12 (2007): 979–90. http://dx.doi.org/10.2165/00002512-200724120-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Cheung, C. M. G., O. M. Durrani, and P. Stavrou. "Peripapillary choroidal neovascularisation in sarcoidosis." Ocular Immunology and Inflammation 10, no. 1 (2002): 69–73. http://dx.doi.org/10.1076/ocii.10.1.69.10324.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Groeneveld, Erwin, and Paul Eliadis. "Interferon for subfoveal choroidal neovascularisation." Australian and New Zealand Journal of Ophthalmology 21, no. 2 (1993): 133–34. http://dx.doi.org/10.1111/j.1442-9071.1993.tb00769.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Kaplan, H. "Submacular surgery for choroidal neovascularisation." British Journal of Ophthalmology 80, no. 2 (1996): 101. http://dx.doi.org/10.1136/bjo.80.2.101.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Lee, M. S. "Choroidal neovascularisation associated with meningioma." British Journal of Ophthalmology 89, no. 10 (2005): 1384–85. http://dx.doi.org/10.1136/bjo.2005.071696.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Postelmans, L., P. Coquelet, C. Verougstraete, and F. Willermain. "Treatment of peripapillary choroidal neovascularisation." British Journal of Ophthalmology 92, no. 5 (2008): 721–22. http://dx.doi.org/10.1136/bjo.2007.135095.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Yip, Vivien C., Leonard W. Yip, and Augustinus Laude. "Subconjunctival bevacizumab for iris neovascularisation." Lancet Diabetes & Endocrinology 2, no. 6 (2014): 449–50. http://dx.doi.org/10.1016/s2213-8587(14)70070-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Cann, StephenA, JohannesP van Netten, TearaL Ashby, MichaelJ Ashwood-Smith, and NicholasG van der Westhuizen. "Role of lymphagenesis in neovascularisation." Lancet 346, no. 8979 (1995): 903. http://dx.doi.org/10.1016/s0140-6736(95)92744-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Rowson, Neil J., John K. G. Dart, and Roger J. Buckley. "Corneal neovascularisation in acute hydrops." Eye 6, no. 4 (1992): 404–6. http://dx.doi.org/10.1038/eye.1992.83.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Graham, E. M., M. R. Stanford, J. S. Shilling, and M. D. Sanders. "Neovascularisation associated with posterior uveitis." British Journal of Ophthalmology 71, no. 11 (1987): 826–33. http://dx.doi.org/10.1136/bjo.71.11.826.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ohnishi, Yoshitaka, Tatsuro Ishibashi, and Takuji Sagawa. "Fluorescein gonioangiography in diabetic neovascularisation." Graefe's Archive for Clinical and Experimental Ophthalmology 232, no. 4 (1994): 199–204. http://dx.doi.org/10.1007/bf00184005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Hummel, T., P. Burger, N. Frings, et al. "High ligation of the saphenofemoral junction is necessary!" Phlebologie 38, no. 03 (2009): 99–102. http://dx.doi.org/10.1055/s-0037-1622261.

Full text

Abstract:

SummaryNeovascularisation can compromise the success of high ligation and resection of the greater saphenous vein. Studies using duplexultrasound to classify recurrent groin veins have described rates of neovascularisation as high as 60% and raised the question whether high ligation is actually able to prevent groin recurrences. In the present study, recurrent groin veins were excised and examined histologically in order to prove whether neovascularisation is the main cause for sapheno-femoral recurrences. Patients, methods: 419 patients accounting for 458 legs with clinically symptomatic groi

APA, Harvard, Vancouver, ISO, and other styles

35

De Maeseneer, M. G., I. F. Tielliu, P. E. Van Schil, S. G. De Hert, and E. J. Eyskens. "Clinical Relevance of Neovascularisation on Duplex Ultrasound in the Long-Term Follow-up after Varicose Vein Operation." Phlebology: The Journal of Venous Disease 14, no. 3 (1999): 118–22. http://dx.doi.org/10.1177/026835559901400306.

Full text

Abstract:

Objective: To evaluate the clinical relevance of neovascularisation at the saphenous ligation site. Design: Long-term follow-up after previous varicose vein surgery in a single patient group. Setting: Vascular clinic of a university hospital. Patients: Eighty-two patients (106 limbs) with a mean follow-up period of 56 months after correct saphenous ligation were submitted to duplex scanning. Intervention: Clinical assessment and colour duplex scanning of all the operated limbs. Reintervention in 15 limbs with perioperative evaluation of recurrent veins. Main outcome measures: Limbs with and wi

APA, Harvard, Vancouver, ISO, and other styles

36

Haj Najeeb, Bilal, Gabor G. Deak, Ursula Margarethe Schmidt-Erfurth, and Bianca S. Gerendas. "RAP study, report 1: novel subtype of macular neovascularisation type III, cilioretinal MNV3." British Journal of Ophthalmology 105, no. 1 (2020): 113–17. http://dx.doi.org/10.1136/bjophthalmol-2019-315311.

Full text

Abstract:

PurposeTo report on patients with macular neovascularisation type III (MNV3) arising from cilioretinal arteries (CRAs) (cilioretinal macular neovascularisation type III (cMNV3)).MethodsWe reviewed baseline examinations of patients with neovascular age-related macular degeneration using multimodal imaging. We determined the type and distribution of MNV lesions in each cMNV3 case, the range of distances from the fovea, existence of exudative maculopathy, intraretinal haemorrhage and other morphological characteristics. 50 consecutive eyes with usual MNV3 without CRA were included as a control gr

APA, Harvard, Vancouver, ISO, and other styles

37

Dervenis, Nikolaos, Panagiotis Dervenis, and Eleftherios Agorogiannis. "Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response—a scoping review." BMJ Open Ophthalmology 9, no. 1 (2024): e001516. http://dx.doi.org/10.1136/bmjophth-2023-001516.

Full text

Abstract:

Age-related macular degeneration is a major cause of blindness, and the development of anti-vascular endothelial growth factor (VEGF) intravitreal treatments has revolutionised the management of the disease. At the same time, new challenges and unmet needs arose due to the limitations of the current therapeutic options. Neovascularisation development during the course of the disease has a complex pathogenetic mechanism, and several biomarkers and their association with treatment outcomes have been investigated. We reviewed the relevant literature about neovascularisation development and biomar

APA, Harvard, Vancouver, ISO, and other styles

38

&NA;. "Changing times for intraocular neovascularisation, oedema." Inpharma Weekly &NA;, no. 1654 (2008): 9. http://dx.doi.org/10.2165/00128413-200816540-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Tuncel, Alper, Merdan Serin, and Mehmet Bayramicli. "Venous component in scar penetrating neovascularisation." Journal of Plastic Surgery and Hand Surgery 52, no. 1 (2017): 47–52. http://dx.doi.org/10.1080/2000656x.2017.1319848.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Lee, D. K. "Serpiginous choroidopathy presenting as choroidal neovascularisation." British Journal of Ophthalmology 87, no. 9 (2003): 1184–85. http://dx.doi.org/10.1136/bjo.87.9.1184.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Berger, Lisa, and Bernhard M. Stoffelns. "Photodynamic Therapy in Subfoveal Choroidal Neovascularisation." Medical Laser Application 17, no. 4 (2002): 331–40. http://dx.doi.org/10.1078/1615-1615-00078.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

AI-Husainy, S., P. Stavrou, and M. W. Hope-Ross. "Alkali injury complicated by choroidal neovascularisation." Eye 14, no. 6 (2000): 904–5. http://dx.doi.org/10.1038/eye.2000.247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Mehta, J. S., A. S. Jacks, V. Maurino, and A. M. P. Hamilton. "Neovascularisation in a patent chorioretinal anastomosis." Eye 14, no. 6 (2000): 916–18. http://dx.doi.org/10.1038/eye.2000.256.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Menzel-Severing, J. "Emerging techniques to treat corneal neovascularisation." Eye 26, no. 1 (2011): 2–12. http://dx.doi.org/10.1038/eye.2011.246.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

McLEOD, D. "Entry site neovascularisation after diabetic vitrectomy." British Journal of Ophthalmology 84, no. 8 (2000): 810–12. http://dx.doi.org/10.1136/bjo.84.8.810.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Lee, J. "Preretinal neovascularisation associated with choroidal melanoma." British Journal of Ophthalmology 85, no. 11 (2001): 1309–12. http://dx.doi.org/10.1136/bjo.85.11.1309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Aisenbrey, S., F. Gelisken, P. Szurman, and K. U. Bartz-Schmidt. "Surgical treatment of peripapillary choroidal neovascularisation." British Journal of Ophthalmology 91, no. 8 (2007): 1027–30. http://dx.doi.org/10.1136/bjo.2006.108118.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Binder, S. "Surgical treatment of peripapillary choroidal neovascularisation." British Journal of Ophthalmology 91, no. 8 (2007): 990–91. http://dx.doi.org/10.1136/bjo.2007.114009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Bradbury, Jane. "Integrin antagonists may prevent retinal neovascularisation." Lancet 347, no. 9010 (1996): 1249. http://dx.doi.org/10.1016/s0140-6736(96)90751-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Gupta, B., S. Parvizi, and M. D. Mohamed. "Bietti crystalline dystrophy and choroidal neovascularisation." International Ophthalmology 31, no. 1 (2010): 59–61. http://dx.doi.org/10.1007/s10792-010-9406-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!